KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 63 filers reported holding KINNATE BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is 193.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,565 | +30.5% | 964,881 | +16.2% | 0.01% | +12.5% |
| Q4 2023 | $1,966 | +90.9% | 830,493 | +12.7% | 0.01% | +100.0% |
| Q3 2023 | $1,030 | -21.0% | 736,686 | +71.0% | 0.00% | -20.0% |
| Q2 2023 | $1,304 | +628.5% | 430,802 | +1389.9% | 0.01% | +400.0% |
| Q1 2023 | $179 | +167.2% | 28,915 | +163.2% | 0.00% | – |
| Q4 2022 | $67 | -99.9% | 10,986 | +34.7% | 0.00% | -100.0% |
| Q3 2022 | $97,000 | -28.7% | 8,156 | -24.2% | 0.00% | 0.0% |
| Q2 2022 | $136,000 | – | 10,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|